Ultrasound-Guided PCNL — Why Are We Still Performing Exclusively Fluoroscopic Access?
- Published in:
- Current Urology Reports, 2023, v. 24, n. 7, p. 335, doi. 10.1007/s11934-023-01163-8
- By:
- Publication type:
- Article
Works matching IS 15272737 AND DT 2023 AND VI 24 AND IP 7
Results: 5
1
2
Role of the Renin–Angiotensin System Components in Renal Cell Carcinoma: A Literature Review.
- Published in:
- Current Urology Reports, 2023, v. 24, n. 7, p. 345, doi. 10.1007/s11934-023-01160-x
- By:
- Publication type:
- Article
3
Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?
- Published in:
- Current Urology Reports, 2023, v. 24, n. 7, p. 299, doi. 10.1007/s11934-023-01159-4
- By:
- Publication type:
- Article
4
Review of Active Surveillance in Underrepresented and High-Risk Populations: Feasibility and Safety.
- Published in:
- Current Urology Reports, 2023, v. 24, n. 7, p. 307, doi. 10.1007/s11934-023-01158-5
- By:
- Publication type:
- Article
5
Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma.
- Published in:
- Current Urology Reports, 2023, v. 24, n. 7, p. 317, doi. 10.1007/s11934-023-01157-6
- By:
- Publication type:
- Article